When you have type 2 diabetes, your pancreas does not produce enough insulin to balance your blood sugar levels
UNESPA (Madrid, Spain), Fundacin Eugenio Rodrguez Pascual (FERP-2023-076), Programa de Becas Gilead a la Investigacin Biomdica (GLD23_00063)
doi: 10.3389/fmicb.2017.01765 13 CekanaviciuteE.YooB
The compound is frequently referred to as a triple-hormone-receptor agonist retatrutide because it simultaneously targets: GLP-1 receptor pathways Glucagon receptor pathways Glucose-dependent insulinotropic polypeptide receptor pathways This triple agonist mechanism differentiates retatrutide from earlier GLP-1 receptor agonist compounds and other research peptides currently studied for obesity and metabolic dysfunction
Since tirzepatide may slow gastric emptying as part of its mechanism of action, patients with pre-existing severe gastroparesis could experience worsening of symptoms, including nausea, vomiting, and potential complications related to delayed gastric emptying
Want to explore how market shifts could impact your business next year
